Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-4833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 |
filingDate |
2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d79a77b8abb1d4369db55133bb75a816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bfaf008def32ada23bcfe6c18bd313d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9377d6b97b70435ae08a136c852c8028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee1940635a6aa11db7ad86ae9fe1993 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f674ba66c0a541ee100603837f84933f |
publicationDate |
2016-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016101187-A1 |
titleOfInvention |
Nonlinear saccharide conjugates |
abstract |
This specification is directed to nonlinear saccharide conjugates that comprise polysaccharides that are linked to at least two peptides that comprise T-cell epitopes and have no conformational B-cell epitopes where one of the peptides is linked to an internal saccharide so that the conjugates have a branched (i.e., nonlinear) structure. The specification also provides methods of manufacturing these conjugates, methods of formulating these conjugates in compositions for use as vaccines and methods of using the compositions to induce an immune response to the capsular saccharide. The specification also provides a new polyepitope carrier peptide comprising the PV1 epitope from polio virus. The new polyepitope carrier peptide can be used in both linear saccharide conjugates as well as the nonlinear saccharide conjugates. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020009993-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020010016-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147866-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707514-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020010000-A1 |
priorityDate |
2012-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |